Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
All Posts By
admin
Rx Summit 2024: The Americans With Disabilities Act: Rights, Remedies, and Protections for People With Substance Use Disorder
April 4, 2024
Rx Summit 2024: Using Federal Civil Rights Statutes to Protect Syringe Service Programs and Other Treatment and Prevention Service Providers
April 3, 2024
Center for U.S. Policy Networking Dinner at Rx Summit in Atlanta, GA
April 2, 2024
Rx Summit 2024: Advocating for Change at the Local and State Levels
April 2, 2024
APhA Institute on Substance Use Disorders Virtual Meeting 2021
May 12, 2021
HHS Expands Access to Buprenorphine for OUD
News
April 27, 2021
North Carolina Prevention Conference 2021
February 23, 2021
Rx Summit 2021: Addressing Social Determinants of Health in Addiction Treatment
February 22, 2021
Rx Summit 2021: Building a Diverse and Informed Bench in Addiction Policy
February 21, 2021
Rx Summit 2021: From Outreach to Outcomes: A Call for Consistent Measures Across Post-Overdose Outreach Interventions
February 20, 2021
APhA Annual Conference 2021: Don’t ‘Just Say No’: Preventing Diversion and Addressing Medical Needs
February 19, 2021
ED Visits for Opioid Poisonings Up 29%
News
February 10, 2021
More
